Cargando…

Challenges to Design and Develop of DNA Aptamers for Protein Targets. II. Development of the Aptameric Affinity Ligands Specific to Human Plasma Coagulation Factor VIII Using SEC-SELEX

Protein specific aptamers are highly applicable affinity ligands in different fields of research and clinical applications. They have been developed against various targets, in particular, bio-macromolecules such as proteins. Among human proteins, the coagulation factors are the most attractive targ...

Descripción completa

Detalles Bibliográficos
Autores principales: Vahidi, Hossein, Nafissi-Varcheh, Nastaran, Kazemi, Bahram, Aboofazeli, Reza, Shahhosseini, Soraya, Tabarzad, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603883/
https://www.ncbi.nlm.nih.gov/pubmed/28979328
_version_ 1783264786505531392
author Vahidi, Hossein
Nafissi-Varcheh, Nastaran
Kazemi, Bahram
Aboofazeli, Reza
Shahhosseini, Soraya
Tabarzad, Maryam
author_facet Vahidi, Hossein
Nafissi-Varcheh, Nastaran
Kazemi, Bahram
Aboofazeli, Reza
Shahhosseini, Soraya
Tabarzad, Maryam
author_sort Vahidi, Hossein
collection PubMed
description Protein specific aptamers are highly applicable affinity ligands in different fields of research and clinical applications. They have been developed against various targets, in particular, bio-macromolecules such as proteins. Among human proteins, the coagulation factors are the most attractive targets for aptamer selection and their specific aptamers have valuable characteristics in therapeutic and analytical applications. In this study, a plasma derived coagulation factor VIII was considered as the protein target for DNA aptamer selection using size exclusion chromatography-SELEX. Potential aptameric oligonucleotides with high affinity and specificity were achieved during eight rounds of selection. Binding affinity constant of selected aptamer and aptameric enriched pool were in nanomolar range that was comparable to monoclonal antibodies. Further improvement studies can result in aptamers that are more promising as an industrial affinity ligand for the purification of anti-hemophilia factor from plasma source.
format Online
Article
Text
id pubmed-5603883
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-56038832017-10-04 Challenges to Design and Develop of DNA Aptamers for Protein Targets. II. Development of the Aptameric Affinity Ligands Specific to Human Plasma Coagulation Factor VIII Using SEC-SELEX Vahidi, Hossein Nafissi-Varcheh, Nastaran Kazemi, Bahram Aboofazeli, Reza Shahhosseini, Soraya Tabarzad, Maryam Iran J Pharm Res Original Article Protein specific aptamers are highly applicable affinity ligands in different fields of research and clinical applications. They have been developed against various targets, in particular, bio-macromolecules such as proteins. Among human proteins, the coagulation factors are the most attractive targets for aptamer selection and their specific aptamers have valuable characteristics in therapeutic and analytical applications. In this study, a plasma derived coagulation factor VIII was considered as the protein target for DNA aptamer selection using size exclusion chromatography-SELEX. Potential aptameric oligonucleotides with high affinity and specificity were achieved during eight rounds of selection. Binding affinity constant of selected aptamer and aptameric enriched pool were in nanomolar range that was comparable to monoclonal antibodies. Further improvement studies can result in aptamers that are more promising as an industrial affinity ligand for the purification of anti-hemophilia factor from plasma source. Shaheed Beheshti University of Medical Sciences 2017 /pmc/articles/PMC5603883/ /pubmed/28979328 Text en © 2017 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Vahidi, Hossein
Nafissi-Varcheh, Nastaran
Kazemi, Bahram
Aboofazeli, Reza
Shahhosseini, Soraya
Tabarzad, Maryam
Challenges to Design and Develop of DNA Aptamers for Protein Targets. II. Development of the Aptameric Affinity Ligands Specific to Human Plasma Coagulation Factor VIII Using SEC-SELEX
title Challenges to Design and Develop of DNA Aptamers for Protein Targets. II. Development of the Aptameric Affinity Ligands Specific to Human Plasma Coagulation Factor VIII Using SEC-SELEX
title_full Challenges to Design and Develop of DNA Aptamers for Protein Targets. II. Development of the Aptameric Affinity Ligands Specific to Human Plasma Coagulation Factor VIII Using SEC-SELEX
title_fullStr Challenges to Design and Develop of DNA Aptamers for Protein Targets. II. Development of the Aptameric Affinity Ligands Specific to Human Plasma Coagulation Factor VIII Using SEC-SELEX
title_full_unstemmed Challenges to Design and Develop of DNA Aptamers for Protein Targets. II. Development of the Aptameric Affinity Ligands Specific to Human Plasma Coagulation Factor VIII Using SEC-SELEX
title_short Challenges to Design and Develop of DNA Aptamers for Protein Targets. II. Development of the Aptameric Affinity Ligands Specific to Human Plasma Coagulation Factor VIII Using SEC-SELEX
title_sort challenges to design and develop of dna aptamers for protein targets. ii. development of the aptameric affinity ligands specific to human plasma coagulation factor viii using sec-selex
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603883/
https://www.ncbi.nlm.nih.gov/pubmed/28979328
work_keys_str_mv AT vahidihossein challengestodesignanddevelopofdnaaptamersforproteintargetsiidevelopmentoftheaptamericaffinityligandsspecifictohumanplasmacoagulationfactorviiiusingsecselex
AT nafissivarchehnastaran challengestodesignanddevelopofdnaaptamersforproteintargetsiidevelopmentoftheaptamericaffinityligandsspecifictohumanplasmacoagulationfactorviiiusingsecselex
AT kazemibahram challengestodesignanddevelopofdnaaptamersforproteintargetsiidevelopmentoftheaptamericaffinityligandsspecifictohumanplasmacoagulationfactorviiiusingsecselex
AT aboofazelireza challengestodesignanddevelopofdnaaptamersforproteintargetsiidevelopmentoftheaptamericaffinityligandsspecifictohumanplasmacoagulationfactorviiiusingsecselex
AT shahhosseinisoraya challengestodesignanddevelopofdnaaptamersforproteintargetsiidevelopmentoftheaptamericaffinityligandsspecifictohumanplasmacoagulationfactorviiiusingsecselex
AT tabarzadmaryam challengestodesignanddevelopofdnaaptamersforproteintargetsiidevelopmentoftheaptamericaffinityligandsspecifictohumanplasmacoagulationfactorviiiusingsecselex